RMD - ResMed Adopts New Operating Model to Accelerate Long-term Growth | Benzinga
- Justin Leong appointed Chief Product Officer, effective immediately.
- Katrin Pucknat appointed Chief Marketing Officer, effective immediately.
- Mike Fliss appointed Chief Revenue Officer, effective immediately.
- Rob Douglas, President and Chief Operating Officer, to retire January 1, 2024.
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD)) today announced a new operating model to accelerate long-term growth. The new operating model introduces dedicated leadership in Product, Revenue, and Marketing to the global executive team. This change aims to increase the velocity of product development and sharpen our customer and brand focus. Ultimately, the goal is to accelerate profitable growth, while driving greater value and improved care throughout the outside hospital care continuum and the patient journey.
"ResMed is the undisputed leader in digital health for respiratory medicine and residential care, and we aspire to make ourselves even more Product-led, Customer-centric, and Brand-enhanced. Today, we are making bold changes to ensure these capabilities are directly represented in our executive leadership team," said Mick Farrell, ResMed's CEO. "We will measure the success of our new operating model through increased product velocity, increased vigilance on long-term profitable revenue delivery, and increased brand engagement with stakeholders."
ResMed's new Product-led, Customer-centric, and Brand-enhanced operating model includes the following executive leadership team:
- Leaders appointed into new roles:
- Chief Product Officer – Justin Leong (previously president, Asia and Latin America)
- Chief ...